SABRA HEALTH CARE REIT INC

Insider Trading & Executive Data

SBRA
NASDAQ
Real Estate
REIT - Healthcare Facilities

Start Free Trial

Get the full insider signal for SBRA

63 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.

Trade-level insider transactions with filing links, transaction codes, and footnotes
Executive compensation trends by role with year-over-year comparisons
Institutional ownership shifts by quarter with top-holder concentration data
Form 144 and Form 8-K monitoring with AI analysis and CSV export tools

Insider Activity Summary

Insider Trades (1Y)
63
8 in last 30 days
Buy / Sell (1Y)
50/13
Acquisitions / Dispositions
Unique Insiders (1Y)
12
Active in past year
Insider Positions
12
Current holdings
Position Status
12/0
Active / Exited
Institutional Holders
414
Latest quarter
Board Members
10

Compensation & Governance

Avg Total Compensation
$3.7M
Latest year: 2024
Executives Covered
5
Comp records available
Form 8-K Events (1Y)
2
Personnel Changes (1Y)
2
Bonus Plan Events (1Y)
0
Organization Changes (1Y)
0
Board Appointments (1Y)
2
Board Departures (1Y)
1

Restricted Sales

Form 144 Filings (1Y)
1
Form 144 Insiders (1Y)
1
Planned Sale Shares (1Y)
11.0K
Planned Sale Value (1Y)
$192500.00
Price
$20.62
Market Cap
$5.2B
Volume
6,083
EPS
$0.64
Revenue
$774.6M
Employees
58
About SABRA HEALTH CARE REIT INC

Company Overview

Sabra Health Care REIT Inc (ticker: SBRA) is a Real Estate company operating in the REIT - Healthcare Facilities industry that owns and invests in senior housing and healthcare-related real estate, with a portfolio of 359 properties following active capital-recycling (acquisitions and dispositions). The June 30, 2025 quarter showed stable rental revenue (~$99.8M) and a meaningful rise in resident fees and services (up 16% YoY), driven by acquisitions, conversions to the managed portfolio, higher occupancy and rate increases; FFO and AFFO improved materially and the company reported strong liquidity (~$1.2B). Management is focused on capital recycling, maintaining dividend payments (paid $142.8M YTD), and balance-sheet flexibility (redeemed $500M 2026 notes and arranged a $500M term loan). Key operational risks cited include tenant/borrower stress from higher rates, labor/cost pressures tied to CMS and reimbursement changes, and collectability of lease receivables.

Executive Compensation Practices

As a Real Estate REIT - Healthcare Facilities company, executive pay is likely tied to cash-based operating metrics: FFO and AFFO per share, same-store cash NOI/occupancy, and dividend sustainability — these metrics drove recent performance and will likely be primary bonus and incentive targets. Given the company’s active capital-recycling strategy and recent refinancing activity, metrics that measure successful dispositions/acquisitions, leverage management (debt covenant compliance, liquidity) and preservation of dividend coverage will be important for short‑ and long‑term incentive design. One-time items reported this quarter (property sale gains, swap reclassification) can distort pay triggers, so Sabra may use normalized/adjusted FFO/AFFO or multi-year performance stock units (TSR/FFO-based PSUs) to align pay with sustainable cash generation. Typical REIT practices—base salary plus annual cash bonuses and long-term equity with multi-year vesting—are expected, and tax/REIT distribution constraints (90% distribution rule) limit free cash for pay increases versus capital needs.

Insider Trading Considerations

Insider transaction activity at Sabra will often cluster around material events that change perceived cash flow or balance-sheet risk: earnings/FFO beats, property dispositions/acquisitions, dividend declarations, and refinancing milestones (e.g., the recent $500M term loan and note redemption). Because the company uses capital recycling and occasionally records one-time gains, watch for scheduled insider sales under Rule 10b5‑1 plans (common in REITs) as well as clustered purchases/sales shortly after refinancing or liquidity improvements. Regulatory and operational risks—CMS reimbursement changes, staffing and collection issues—can produce rapid reassessments of valuation and trigger insider activity; also expect standard blackout windows around earnings and material event disclosures, Section 16 reporting on Form 4, and potential internal policies limiting hedging or pledging of shares. Monitor Form 4s around dispositions, refinancing announcements, dividend/ex‑dividend dates and any unusual clustering relative to normalized FFO/AFFO trends.

Unlock Full Insider Trading Data
Get complete access to insider trades, executive compensation, institutional holdings, and AI-powered analysis for SABRA HEALTH CARE REIT INC and thousands of other companies.
Individual insider trade details with transaction history
Executive compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Form 144 restricted sale filings with details
Form 8-K governance events and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
No credit card required
Cancel anytime